Rhabdomyosarcoma. From the laboratory to the clinic

P. J. Houghton, D. N. Shapiro, J. A. Houghton

Research output: Contribution to journalArticlepeer-review

12 Scopus citations


The prospect of identifying and developing new agents for treatment of rhabdomyosarcomas is discussed in the light of current prognosis for children with advanced stage disease. Preliminary attempts to identify tumor-specific agents using in vitro cell culture show potential promise, but as yet remain unproven. The more complex system of identifying therapeutically active agents using human tumor xenografts has demonstrated usefulness. The potential problems associated with this system are discussed.

Original languageEnglish (US)
Pages (from-to)349-364
Number of pages16
JournalPediatric Clinics of North America
Issue number2
StatePublished - 1991
Externally publishedYes

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health


Dive into the research topics of 'Rhabdomyosarcoma. From the laboratory to the clinic'. Together they form a unique fingerprint.

Cite this